期刊文献+

高脂血症与血浆凝血因子Ⅶ活性的相关性研究

The correlation study between hyperlipidemia and the activity of coagulation factor Ⅶ
下载PDF
导出
摘要 目的:探讨高脂血症与血浆凝血因子Ⅶ活性升高的相关性。方法:比较高脂血症病人(100例)和正常血脂对照组(109例)间血浆凝血因子活性的差别;用直线相关和多元逐步回归分析血浆Ⅶ活性和血脂等之间的线性相关关系;Logistic回归分析血浆Ⅶ活性对高脂血症发病的影响程度。结果:高脂血症组凝血因子Ⅶ(FⅦ)活性(156.11%±37.61%)高于正常对照组(132.50%±24.01%),(P<0.001);FⅦ活性与年龄、TC、TG、LDL-C、FIB、GLU呈正相关(P<0.01)、与TC、TG、HDL-C、FIB呈线性关系;Logistic回归分析高脂血症与BMI、FⅦ有统计学意义,P<0.01。结论:高脂血症病人血浆凝血因子Ⅶ活性升高,呈显著正相关。FⅦ活性的增高对高脂血症病人的动脉血栓形成发病可能有直接的关系。 Objective:To investigate the correlation between the hyperlipidemia and the activity of coagulation factor Ⅶ.Methods:The activity of factor Ⅶ in normal control group was compared with that in the hyperlipaemic group, the correlation between blood lipids and the activity of factor Ⅶ and its influence on hyperlipidemia was also analyzed.Results:The activity of factor Ⅶ in the hyperlipaemic group was significantly higher than that in the normal control group (156.11%±37.61% vs 132.50%±24.01%, P<0.001), positive correlation was found between the activity of factor Ⅶ and age, TC, TG, LDL-C, FIB, GLU (P<0.01).Conclusion:There was significant positive correlation between blood lipids and the activity of factor Ⅶ, the increase of the activity of factor Ⅶ may induce the rate of recurrence of arterial occlusion.
机构地区 浙江医院
出处 《中国卫生检验杂志》 CAS 2005年第6期668-669,共2页 Chinese Journal of Health Laboratory Technology
基金 浙江省医药卫生科学基金资助项目(2003B019)
  • 相关文献

参考文献11

  • 1Folsom AR, Wu KK, Chambless LE, et al. Determinants of population changes in fibrinogen and factor W over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study[ J ]. Arterioscler Thromb Vase Biol, 2000,20(2) :601 - 606.
  • 2Sorensen BB, Hedner U, Erhardtsen E. rFⅦai in acute coronary syndromes[ J ]. Semin Vaac Med, 2003,3(2) : 199 -204.
  • 3Green D, Chamberlain MR, Ruth K J, et al. Factor Ⅶ, cholesterol and triglycerides:The CARIA Study Coronary Artery Risk Derelopment in Young Adults Study[ J ]. Arterioscler Thromb Vaac Biol, 1997,17:51.
  • 4Griffin JH, Fernandez JA, Deguchi H. Plasma lipoproteins, hemostasis and hrombosis[ J ]. Thromb Haemost,2001,86 ( 1 ) :386 -394.
  • 5Cardigan RA, Crook M, Mackie 1J,et al. Plasma levels of factor Ⅻa and factor Ⅶa are increased but not related in primary hyperlipidaemia [ J]. Blood Coagul Fibrinolysis, 2001,12( 3 ) : 187 - 192.
  • 6Lindman AS, Muller H, Seljeflot I,et al. Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor Ⅶ and serum cholinecontaining phospholipids[J]. Br J Nutr, 2003,90(2) :329 - 336.
  • 7Bozzini C, Girelli D, Bemardi F, et al. Influence of polymorphisms in the factor W gene promoter on activated factor W levels and on the risk of myocardial infarction in advanced coronary atherosclerosis [J].Thromb Haemost,2004,92(3) : 541 - 549.
  • 8Stengard JH, Salomaa V, Rasi V ,et al. Utility of the Arg/Gln polymorphism of the factor  Ⅶ (FⅦ) gene, serum lipid levels and body mass index in the prediction of the Ⅶ:C and FⅦ:AG in North Karelia; a cross-sectional and prospective study [ J ]. Blood Coagul Fibrinolysis,2001,12(6) :445 - 452.
  • 9Porreca E, Di Febbo C, Amore C,et al. Effect of lipid - lowering treat-ment on factor W profile in hyperlipidemic patients[ J ]. Thromb Hacmost,2000,84(5) : 789-793.
  • 10Griffin JH, Fernandez JA, Deguchi H. Plasma lipoproteins, hemostasis and thrombosis[ J ]. Thromb Haemost,2001,86( 1 ) :386 - 394.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部